Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack
NCT ID: NCT00363753
Last Updated: 2019-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE1
INTERVENTIONAL
2006-08-31
2007-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime)
NCT06638151
Role of Anti-platelet in Treatment of Acute Ischemic Stroke
NCT03266731
A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel
NCT03766581
Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke
NCT03661411
Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke
NCT04142151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
aspirin versus clopidogrel
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stroke or transient ischemic attack (TIA) while taking aspirin within one week of consent.
* Women of child-bearing potential will be included only if there is a negative pregnancy test and they agree to birth control during the treatment period.
Exclusion Criteria
* Any medical indication for anticoagulation, except subcutaneous heparin for deep vein thrombosis prophylaxis.
* Allergy to aspirin or clopidogrel.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Diego
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matt B Jensen, MD
Role: PRINCIPAL_INVESTIGATOR
UCSD Stroke Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCSD Hillcrest
San Diego, California, United States
UCSD
San Diego, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UCSD IRB #060452
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.